Variability in COPD: The PLATINO Study Viewpoint;Variabilidad en la EPOC. Una visión a través del estudio PLATINO

Archivos de Bronconeumologia

Volumn 48, Issue 4, 2012, Pages 105-106

  López Varela, María Victorina ^a   Montes de Oca, María ^b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY VOLUME; BODY WEIGHT; BRONCHOSPIROGRAPHY; CLINICAL FEATURE; COMORBIDITY; DETERIORATION; DEVELOPING COUNTRY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FOLLOW UP; FUNCTIONAL STATUS; GENERAL HEALTH STATUS ASSESSMENT; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG CAPACITY; MEXICO CITY; MORBIDITY; MORTALITY; PHENOTYPE; PHYSICAL DISABILITY; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEX DIFFERENCE;

COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GENETIC VARIATION; HUMANS; MULTICENTER STUDIES AS TOPIC; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SOUTH AMERICA; URBAN POPULATION;

BRONCHODILATING AGENT;

EID: 84858285087     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.09.007     Document Type: Article

References (20)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
2. Peces-Barba G., Barberá J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L., et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Arch Bronconeumol 2008, 44:271-281.
3. Pena V.S., Miravitlles M., Gabriel R., Jiménez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographic variations in prevalence and under-diagnosis of COPD: Results of the IBERPOC multicentre epidemiological study. Chest 2000, 118:981-989.
4. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160:1683-1689.
5. Zhong N., Wang C., Yao W., Chen P., Kang J., Huang S., et al. Prevalence of chronic obstructive pulmonary disease in China: A large population-based survey. Am J Respir Crit Care Med 2007, 176:753-760.
6. Buist A.S., McBurnie M.A., Vollmer W.M., Gillespie S., Burney P., Mannino D.M., et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007, 370:741-750.
7. Menezes A.M.B., Pérez-Padilla R., Jardim J.R.B., Muiño A., López M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet 2005, 366:1875-1881.
8. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S., Mannino D.M. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J 2006, 28:523-532.
9. García Aymerich J., Agustí A., Barbera J.A., Belfa J., Farrero E., Ferrer A., et al. La heterogeneidad fenotípica de la EPOC. Arch Bronconeumol 2009, 45:129-138.
10. Sobradillo P., García Aymerich J., Agustí A. Fenotipos clínicos de la EPOC. Arch Bronconeumol 2010, 46:8-11.
11. Vestbo J., Anderson W., Coxson H.O., Crim C., Dawber F., Edwards L., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869-873. ECLIPSE investigators.
12. Han M.K., Agustí A., Calverley P.M., Celli B.R., Criner G., Curtis J.L., et al. Chronic ObstructivePulmonary Disease Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010, 182:598-604.
13. Menezes A.M., Victora C.G., Pérez-Padilla R. The Platino Project: Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 2004, 4:15.
14. Tálamo C., de Oca M.M., Halbert R., Perez-Padilla R., Jardim J.R., Muiño A., et al. Diagnostic labelling of chronic obstructive pulmonary disease in five Latin American cities. Chest 2007, 131:60-67.
15. López Varela M.V., Muiño A., Pérez Padilla R., Jardim J.R., Tálamo C., Montes de Oca M., et al. Tratamiento de la EPOC en 5 ciudades de América Latina: estudio PLATINO. Arch Bronconeumol 2008, 44:58-64.
16. Montes de Oca M., Tálamo C., Halbert R.J., Pérez-Padilla R., López M.V., Muiño A., et al. Health status perception and airflow obstruction in five Latin American cities: The PLATINO study. Respir Med 2009, 103:1376-1382.
17. Montes de Oca M., Tálamo C., Pérez-Padilla R., Jardim J.R., Muiño A., López M.V., et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: The PLATINO study. Respir Med 2008, 102:642-650.
18. Montes de Oca M., Pérez-Padilla R., Tálamo C., Halbert R.J., Moreno D., López M.V., et al. Acute bronchodilator responsiveness in subjects with and without airflow obstruction in five Latin American cities: The PLATINO study. Pulm Pharmacol Ther 2010, 23:29-35.
19. Montes de Oca M., Tálamo C., Halbert R.J., Pérez-Padilla R., López M.V., Muiño A., et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities The Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar (PLATINO) Study. Chest 2009, 136:71-78.
20. López Varela M.V., Montes de Oca M., Halbert R., Muiño A., Pérez-Padilla R., Tálamo C., et al. Sex-Related differences in COPD in five Latin American cities: The PLATINO study. Eur Respir J 2010, 36:1034-1041.